$1.9 Billion is the total value of QVT Financial LP's 52 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRput | $181,654,250 | +7.1% | 475,000 | 0.0% | 9.58% | -19.1% | |
| NXST | NEXSTAR MEDIA GROUP INC | $29,008,597 | +4.9% | 165,735 | 0.0% | 1.53% | -20.7% | |
| PALO ALTO NETWORKS INCnote 0.750% 7/0 | $23,730,125 | -14.8% | 15,000,000 | 0.0% | 1.25% | -35.6% | ||
| NNI | NELNET INCcl a | $19,480,849 | +14.6% | 214,665 | 0.0% | 1.03% | -13.4% | |
| CHK | CHESAPEAKE ENERGY CORP | $17,392,297 | +0.2% | 184,299 | 0.0% | 0.92% | -24.3% | |
| ATEX | ANTERIX INC | $16,211,782 | -9.9% | 503,941 | 0.0% | 0.86% | -31.9% | |
| BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $14,810,519 | +15.7% | 47,946 | 0.0% | 0.78% | -12.5% | |
| MMYT | MAKEMYTRIP LIMITED MAURITIUS | $13,536,346 | -10.2% | 490,981 | 0.0% | 0.71% | -32.1% | |
| ARGX | ARGENX SEsponsored adr | $12,311,217 | +7.3% | 32,498 | 0.0% | 0.65% | -19.0% | |
| NYT | NEW YORK TIMES COcl a | $10,288,100 | +12.9% | 316,947 | 0.0% | 0.54% | -14.8% | |
| STRIDE INCnote 1.125% 9/0 | $8,971,723 | -12.2% | 10,000,000 | 0.0% | 0.47% | -33.7% | ||
| EAGLE BULK SHIPPING INCnote 5.000% 8/0 | $8,029,102 | +13.8% | 4,850,000 | 0.0% | 0.42% | -14.0% | ||
| IMGN | IMMUNOGEN INC | $6,824,464 | +3.8% | 1,375,900 | 0.0% | 0.36% | -21.6% | |
| MSTR | MICROSTRATEGY INCput | $6,597,162 | -33.3% | 46,600 | 0.0% | 0.35% | -49.6% | |
| MAKEMYTRIP LIMITED MAURITIUSnote 2/1 | $6,459,602 | -5.2% | 6,500,000 | 0.0% | 0.34% | -28.2% | ||
| ALLT | ALLOT LTD | $6,044,854 | -12.2% | 1,757,225 | 0.0% | 0.32% | -33.7% | |
| REDFIN CORPnote 1.750% 7/1 | $4,748,368 | +4.1% | 5,000,000 | 0.0% | 0.25% | -21.4% | ||
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $4,336,024 | -33.3% | 678,564 | 0.0% | 0.23% | -49.6% | |
| GTN | GRAY TELEVISION INC | $3,261,348 | -21.9% | 291,452 | 0.0% | 0.17% | -40.9% | |
| JOYY INCnote 0.750% 6/1 | $953,235 | +2.3% | 1,000,000 | 0.0% | 0.05% | -23.1% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $458,357 | +22.2% | 4,429 | 0.0% | 0.02% | -7.7% | |
| SRPT | SAREPTA THERAPEUTICS INC | $403,901 | +17.1% | 3,117 | 0.0% | 0.02% | -12.5% | |
| MRSN | MERSANA THERAPEUTICS INC | $367,170 | -13.4% | 62,657 | 0.0% | 0.02% | -36.7% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $312,239 | -2.7% | 19,613 | 0.0% | 0.02% | -27.3% | |
| APPHW | APPHARVEST INC*w exp 01/29/202 | $47,550 | -72.0% | 500,000 | 0.0% | 0.00% | -75.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
| 13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.